R Paul Wadwa Selected Research

R Paul Wadwa Research Topics

Disease

66	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2022 - 05/2005
14	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 06/2012
7	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 03/2007
5	Hyperglycemia 01/2022 - 01/2018
5	Ketosis 09/2017 - 01/2014
4	Type 2 Diabetes Mellitus (MODY) 11/2020 - 04/2010
4	Insulin Resistance 01/2019 - 01/2006
2	Body Weight (Weight, Body) 01/2021 - 01/2021
2	Dyslipidemias (Dyslipidemia) 11/2020 - 05/2005
2	Diabetes Mellitus 01/2019 - 07/2014
2	Inflammation (Inflammations) 11/2018 - 05/2014
2	Periodontal Diseases (Periodontal Disease) 04/2016 - 01/2010
2	Albuminuria 11/2014 - 09/2007
2	Obesity 08/2013 - 01/2012
2	Hypertension (High Blood Pressure) 08/2006 - 01/2006
1	Infections 12/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2019
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 10/2019
1	Pain (Aches) 01/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 05/2016
1	Unconsciousness (Loss of Consciousness) 02/2016
1	Seizures (Absence Seizure) 07/2015
1	Hypertriglyceridemia 11/2014
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 07/2014
1	Coronary Disease (Coronary Heart Disease) 09/2007
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2007
1	Neoplasms (Cancer) 01/2006
1	Hyperproinsulinemia 01/2006
1	Rheumatoid Arthritis 01/2006
1	Hepatitis 01/2006

Drug/Important Bio-Agent (IBA)

27	Insulin (Novolin)FDA Link 01/2022 - 01/2006
23	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 01/2006
11	LipidsIBA 01/2019 - 05/2005
7	Hemoglobins (Hemoglobin)IBA 01/2020 - 10/2013
6	CholesterolIBA 11/2020 - 05/2005
4	Triglycerides (Triacylglycerol)IBA 11/2019 - 08/2006
4	SuspensionsIBA 09/2017 - 01/2014
4	Glucagon (Glukagon)FDA Link 10/2016 - 01/2006
3	Blood Glucose (Blood Sugar)IBA 01/2020 - 01/2014
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2019 - 01/2013
3	Fibrinogen (Factor I)FDA Link 11/2018 - 01/2006
3	AdiponectinIBA 11/2018 - 09/2007
3	LDL CholesterolIBA 12/2017 - 03/2009
3	oxidized low density lipoproteinIBA 11/2014 - 01/2006
3	HDL CholesterolIBA 11/2014 - 08/2006
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2019 - 07/2014
2	Metformin (Glucophage)FDA LinkGeneric 09/2019 - 12/2018
2	CarbohydratesIBA 01/2019 - 12/2017
2	KetonesIBA 09/2017 - 01/2014
2	Uric Acid (Urate)IBA 05/2016 - 05/2014
2	ApolipoproteinsIBA 11/2014 - 03/2009
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2007 - 03/2007
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 06/2022
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2021
1	SteroidsIBA 12/2019
1	lathosterolIBA 11/2019
1	campesterolIBA 11/2019
1	gamma-sitosterol (beta-sitosterol)IBA 11/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2019
1	UromodulinIBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	AlbuminsIBA 01/2019
1	LeptinIBA 11/2018
1	Proprotein Convertase 9IBA 12/2017
1	PowdersIBA 04/2016
1	Insulin Lispro (Humalog)FDA Link 03/2015
1	Insulin Aspart (NovoLog)FDA Link 03/2015
1	Dietary Fiber FDA Link 05/2014
1	Interleukin-6 (Interleukin 6)IBA 05/2014
1	V 70 (V70)IBA 01/2014
1	C-Reactive ProteinIBA 01/2014
1	hydroxide ionIBA 01/2013
1	Vitamin D FDA LinkGeneric 01/2013
1	Biomarkers (Surrogate Marker)IBA 11/2011
1	Cystatin CIBA 11/2011
1	Lipoproteins (Lipoprotein)IBA 03/2009
1	Angiotensin IIIBA 09/2007
1	Type 1 Angiotensin ReceptorIBA 03/2007
1	AngiotensinogenIBA 03/2007
1	Angiotensin Receptor AntagonistsIBA 03/2007
1	HomocysteineIBA 01/2006
1	Plasminogen Activator Inhibitor 1IBA 01/2006
1	ProinsulinIBA 01/2006
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2006
1	HDL LipoproteinsIBA 10/2005

Therapy/Procedure

19	Glycemic Control 01/2022 - 03/2009
8	Therapeutics 06/2022 - 02/2016
3	Artificial Pancreas 01/2022 - 12/2017
1	Injections 01/2022
1	Oral Hygiene (Dental Hygiene) 01/2010
1	Toothbrushing 01/2010